CHEK2 and cancer: Mutations in the cell cycle checkpoint kinase 2 (CHEK2) tumor suppressor gene are associated with multi-organ cancer susceptibility including cancers of the breast, prostate, bladder, kidney, thyroid, stomach and colon [1–11].